Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
IGM Biosciences, Inc.
IGM Biosciences, Inc.
Novartis
Rutgers, The State University of New Jersey
Eastern Cooperative Oncology Group
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center